Cargando…

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

BACKGROUND: Advanced non-small cell lung cancer (NSCLC) represents a significant unmet medical need. Despite advances with targeted therapies in a small subset of patients, fewer than 20% of patients survive for more than two years after diagnosis. Cancer vaccines are a promising therapeutic approac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebastian, Martin, Papachristofilou, Alexandros, Weiss, Christian, Früh, Martin, Cathomas, Richard, Hilbe, Wolfgang, Wehler, Thomas, Rippin, Gerd, Koch, Sven D, Scheel, Birgit, Fotin-Mleczek, Mariola, Heidenreich, Regina, Kallen, Karl-Josef, Gnad-Vogt, Ulrike, Zippelius, Alfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195907/ https://www.ncbi.nlm.nih.gov/pubmed/25288198 http://dx.doi.org/10.1186/1471-2407-14-748

Ejemplares similares

A novel, disruptive vaccination technology: Self-adjuvanted RNActive(®) vaccines
por: Kallen, Karl-Josef, et al.
Publicado: (2013)

Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy
por: Hong, Henoch S., et al.
Publicado: (2016)

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
por: Papachristofilou, Alexandros, et al.
Publicado: (2019)

A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses
por: Kallen, Karl-Josef, et al.
Publicado: (2013)

A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive(®)-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part
por: Koch, Sven D, et al.
Publicado: (2014)

Self-adjuvanted RNActive(® )vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
por: Kübler, Hubert, et al.
Publicado: (2015)

RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile
por: Heidenreich, Regina, et al.
Publicado: (2015)

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
por: Fotin-Mleczek, Mariola, et al.
Publicado: (2014)

Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study
por: Fuchs, Julia, et al.
Publicado: (2021)

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Rauch, Susanne, et al.
Publicado: (2021)

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
por: Thess, Andreas, et al.
Publicado: (2015)

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
por: Lutz, Johannes, et al.
Publicado: (2017)

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
por: Läubli, Heinz, et al.
Publicado: (2017)

mRNA mediates passive vaccination against infectious agents, toxins, and tumors
por: Thran, Moritz, et al.
Publicado: (2017)

Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
por: Edwards, Darin K., et al.
Publicado: (2017)

In Reply to Bevelacqua et al
por: Finazzi, Tobias, et al.
Publicado: (2021)

Kann die Radiotherapie gegen COVID-19-Pneumonien helfen?
por: Papachristofilou, Alexandros, et al.
Publicado: (2021)

In regard to Hess et al.
por: Finazzi, Tobias, et al.
Publicado: (2022)

Brain-Gut Interactions in IBS
por: Fichna, Jakub, et al.
Publicado: (2012)

Impact of patient and treatment characteristics on heart and lung dose in adjuvant radiotherapy for left-sided breast cancer
por: Finazzi, Tobias, et al.
Publicado: (2019)

“Connection Failed”: A Word of Caution on Telemedicine in Radiation Oncology
por: Finazzi, Tobias, et al.
Publicado: (2020)

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
por: Pircher, Andreas, et al.
Publicado: (2017)

Upfront consolidation treatment with (131)I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
por: Feng, Jianhua, et al.
Publicado: (2020)

EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
por: Baty, Florent, et al.
Publicado: (2013)

Modelling of IBS
por: Zampetakis, Michail
Publicado: (2019)

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
por: Fichna, Jakub, et al.
Publicado: (2013)

Objective consensus from decision trees
por: Putora, Paul Martin, et al.
Publicado: (2014)

Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
por: Martin, Kea, et al.
Publicado: (2015)

Consolidation
por: Lee, Kyung Soo, et al.
Publicado: (2013)

Neuronal polarity: consolidation for growth, growth for consolidation
por: Gärtner, Annette, et al.
Publicado: (2009)

Expert consolidation in Oracle Database 12c
por: Bach, Martin
Publicado: (2013)

Contingency Plans in a Radiation Oncology Department Amid the 2019-nCoV Outbreak in Switzerland
por: Papachristofilou, Alexandros, et al.
Publicado: (2020)

COVID-19-Pandemie: Wie können sich onkologische Kliniken wappnen?*
por: Papachristofilou, Alexandros, et al.
Publicado: (2020)

Modeling IBS and cooling
por: Boine-Frankenheim, Oliver
Publicado: (2010)

IBS spatial resolution
por: Johnson, CD
Publicado: (1972)

TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M
por: Henström, Maria, et al.
Publicado: (2017)

Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial
por: Schlichting, Michael, et al.
Publicado: (2022)

The Consolidation of the CERN Beam Interlock System
por: Johnson, Roland, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sol98gemfu2e0uh0a5e9q3pt6i